ATE445412T1 - Ein virus der infektiösen bronchitis mit veränderten spike-gen - Google Patents

Ein virus der infektiösen bronchitis mit veränderten spike-gen

Info

Publication number
ATE445412T1
ATE445412T1 AT04716603T AT04716603T ATE445412T1 AT E445412 T1 ATE445412 T1 AT E445412T1 AT 04716603 T AT04716603 T AT 04716603T AT 04716603 T AT04716603 T AT 04716603T AT E445412 T1 ATE445412 T1 AT E445412T1
Authority
AT
Austria
Prior art keywords
infectious bronchitis
ibv
altered
bronchitis virus
spike gene
Prior art date
Application number
AT04716603T
Other languages
English (en)
Inventor
David Cavanagh
Paul Britton
Ian Tarpey
Original Assignee
Intervet Int Bv
Animal Health Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Animal Health Inst filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE445412T1 publication Critical patent/ATE445412T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04716603T 2003-03-03 2004-03-03 Ein virus der infektiösen bronchitis mit veränderten spike-gen ATE445412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075623 2003-03-03
PCT/EP2004/050247 WO2004078203A2 (en) 2003-03-03 2004-03-03 Infectious bronchitis virus with an altered spike gene

Publications (1)

Publication Number Publication Date
ATE445412T1 true ATE445412T1 (de) 2009-10-15

Family

ID=32946897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04716603T ATE445412T1 (de) 2003-03-03 2004-03-03 Ein virus der infektiösen bronchitis mit veränderten spike-gen

Country Status (11)

Country Link
US (1) US7445785B2 (de)
EP (1) EP1610817B1 (de)
AT (1) ATE445412T1 (de)
BR (1) BRPI0407948B1 (de)
DE (1) DE602004023594D1 (de)
DK (1) DK1610817T3 (de)
ES (1) ES2333223T3 (de)
PL (1) PL1610817T3 (de)
PT (1) PT1610817E (de)
SI (1) SI1610817T1 (de)
WO (1) WO2004078203A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072976A1 (es) 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
KR101092977B1 (ko) 2009-03-09 2011-12-26 대한민국 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신
GB0911794D0 (en) 2009-07-07 2009-08-19 Animal Health Inst Chimaeric protein
US20140141043A1 (en) * 2012-11-16 2014-05-22 Auburn University Compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
GB201308057D0 (en) 2013-05-03 2013-06-12 Pirbright Inst The Protein
GB201413020D0 (en) 2014-07-23 2014-09-03 Pribright The Inst Coronavirus
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus
CN110433288A (zh) * 2018-05-03 2019-11-12 乐斯福公司 试剂盒和β-葡聚糖提取物在禽类动物免疫增强中的应用
JP7206383B2 (ja) * 2018-10-31 2023-01-17 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 異種スパイクタンパク質を有する４／９１ ｉｂｖワクチン
UA129764C2 (uk) 2018-10-31 2025-07-30 Бьорінгер Інгельхайм Ветмедіка Гмбх Рекомбінантний вірус інфекційного бронхіту з гетерологічним шиповидним білком та імуногенна композиція, яка їх містить
CN110819599B (zh) * 2019-11-22 2023-05-19 华南农业大学 一种预防台湾型传染性支气管炎的疫苗株
JP2023549787A (ja) 2020-11-12 2023-11-29 インターベット インターナショナル ベー． フェー． キメラコロナウイルススパイクタンパク質をコードする組換えベクターおよびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7350798A (en) 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
BR0108735A (pt) 2000-02-29 2002-12-17 Wyeth Corp Proteção in ovo contra bronquite infecciosa
EP1470218B1 (de) 2001-05-17 2010-07-07 Universiteit Utrecht Coronavirus-ähnliche partikel enthaltende funktionell deletierte genome

Also Published As

Publication number Publication date
EP1610817A2 (de) 2006-01-04
ES2333223T3 (es) 2010-02-18
US20070154489A1 (en) 2007-07-05
BRPI0407948B1 (pt) 2014-10-21
PT1610817E (pt) 2010-01-18
BRPI0407948A (pt) 2006-03-07
US7445785B2 (en) 2008-11-04
WO2004078203A2 (en) 2004-09-16
EP1610817B1 (de) 2009-10-14
WO2004078203A9 (en) 2005-08-25
DE602004023594D1 (de) 2009-11-26
DK1610817T3 (da) 2010-01-25
WO2004078203A3 (en) 2004-11-25
SI1610817T1 (sl) 2010-01-29
PL1610817T3 (pl) 2010-05-31

Similar Documents

Publication Publication Date Title
ATE445412T1 (de) Ein virus der infektiösen bronchitis mit veränderten spike-gen
PH12019501766A1 (en) Porcine coronavirus vaccines
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
WO2004112831A3 (en) High titer recombinant influenza viruses for vaccines and gene therapy
UA85536C2 (en) Viral antigens
NO20090177L (no) Vaksiner for malaria
WO2011106607A3 (en) Subunit vaccines for herpes viruses and methods of use
MY207126A (en) 4/91 ibv vaccine with heterologous spike protein
PH12017500216A1 (en) Vaccine in serotype-9 fowl adenovirus recombinant vector
ATE365206T1 (de) Verfahren zur entwicklung von einem hiv impfstoff
AU2003288510A1 (en) Immunizing fish against viral infection
EP3599247A3 (de) Rekombinantes hämagglutinin-protein des influenzavirus und impfstoff damit
MX2025008754A (es) Composiciones farmaceuticas para la administracion de antigenos de glicoproteina c, glicoproteina d y glicoproteina e del virus del herpes simple y metodos relacionados
WO2006062637A3 (en) Influenza vaccination
CY1106175T1 (el) Αλληλουχιες νουκλεϊνικου οξεος και αμινοξεος μολυσματικου ιου αναιμιας σολομων και χρηση τους ως εμβολια
MX2023002969A (es) Mejora de la inmunidad usando un ligando quimerico del cumulo de diferenciacion 40 (cd40) y vacuna contra el coronavirus.
TN2014000393A1 (en) Modified marek's disease virus, and vaccines made therefrom
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
WO2022047176A3 (en) Single-chain coronavirus viral membrane protein complexes
Oreshkova et al. Preliminary evaluation of a Bunyavirus vector for cancer immunotherapy
ATE330969T1 (de) Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit
MX2023003651A (es) Virus de la diarrea epidemica porcina atenuado.
WO2021245679A8 (en) A sars-cov-2 vaccine
Secko Diversity of avian influenza
TH169741A (th) วัคซีนไวรัสก่อโรคท้องเสียที่ระบาดในหมู

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties